The better result of the combination of IL-6 and the clinical variables may show the additional benefit of IL-6 by capturing patients with an increased severity, such as the association with stroke size, which is not always reflected by the clinical scores e.g., NIHSS [11]. This evidence concerns the gene IL6 and Stroke.